1BELL J H,HARTLEY P S,Cox J S G.Dry powder aerosols Ⅰ:a new powder inhalation device[J].J Pharm Sci,1971,60(10):1559.
2TIMSINA M P,MARTIN G P,MARRIOTr C,et al.Drug-delivery to the respiratory-tract using dry powder inhalers[J].Int J Pharm,1994,101(1-2):1.
3NEWMAN S P,HOLLINGWORTH A,Clark A R.Effect of different modes of inhalation on drug-delivery from a dry powder inhaler[J].Int J pharm,1994,102(1-3):127.
4KASSEM N M,GANDERTON D.The influence of carrier surface on the characteristics of imspirable powder aerosols[J].J Pharm Pharmacol,1990,42(Suppl):11.
5BOSQUILLON C,LOMBRY C,PREAT V,et al.Influence of formnlation exeipients and physical characteristics of inhalation dry powders on their aerosolization performance[J].J Controlled Release,2001,70(3):329.
6SRICHANA T,SUEDEE R,REANMONGKOL W.Cyclodextrin as a potential drug carrier in salbutamol dry powder aerosols:the invitro deposition and toxicity studies of the complexes[J].Respir Med,2001,95(6):513.
7IKEGAMI K,KAWASHIMA Y,TAKEUCHI H,et al.A new agglomerated KSR-592 beta-form crystal system for dry powder inhalation formulation to improve inhalation performance in vitro and in vivo[J].J Controlled Release,2003,88(1):23.
8TAKANO K,HORIO M.Particle design for dry powder inhalation via binderless powder coating by pressure swing granulation[J].Powder Technology,2004,141(3):196.
9STECHEI H,FURKERT F H.Endotoxin testing in inhalation grade lactose-A useful quality parameter[J].Int J Pharm,2004,275(1-2):211.
10STECHKEL H,BOLZEN N.Alternative sugars as potential carriers for dry powder inhalations[J].Int J Pharm,2004,275(1-2):297.
二级参考文献19
1Johnson KA. Preparation of peptide and protein powders for inhalation[J]. Adv Drug Deliv Rev, 1997, 26(1):3-15.
2Newman SP, Hollingworth A, Clark AR, et al. Effect of different modes of inhalation on drug delivery from a dry powderinhaler[J]. Int J Pharm, 1994, 102(2): 127 -132.
3MusarteCJ, Schroeter JD, RosatiJA, et al. Factors affeeting the deposition of inhaled porous drug particles [ J]. J Pharm Sci, 2002, 91(7):1590- 1600.
4Hichey AJ, Concessio NM. Descriptors of irregular particle morphology and powder properties[J]. Adv Drug Deliv Rev,1997, 26(1):29-40.
5Vanbever R, Mintzes JD, Wang J, et al. Formulation and physical characterization of large porous particles for inhalation[J]. Pharm Res, 1999, 16(11):1735-1742.
6Thibert R, Akbarieh M, Tawashi R. Application of fractal dimension to the study of the surface ruggedness of granular solids and excipients[J]. J Pharm Sci, 1988, 77(8):724 - 726.
7奚念朱,主编.药剂学[M].第三版,北京:人民卫生出版社,1998.248.
8Tee SK, Zeng XM, Martin GP, et al. The role of carrier type and fine particle concentration on the deposition of salbutamol sulphate from dry powder aerosols in vitro[J]. J Pharm Pharmcol, 1999, 51(Suppl):324.
9Carter PA, Rowley G, Fletcher EJ, et al. Measurement of electrostatic charge decay in pharmaceutical powders and polymer materials used in dry powder inhaler devices [ J ].Drug Dev Ind Pharm, 1998, 24(11):1083- 1088.
10Cassidy OE, Carter PA, Rowley G, et al. Triboelectrification of spray-dried lactose prepared from different feedstock concentrations[ J]. J Pharm Pharmacol, 2000, 52(1):13- 17.
